RXFP2 Antikörper (AA 103-152)

Produktnummer ABIN2885286

Produktdetails anti-RXFP2 Antikörper

Target: RXFP2 (Relaxin/insulin-Like Family Peptide Receptor 2 (RXFP2))

Bindungsspezifität: AA 103-152

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser RXFP2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Spezifität: RXFP2 Antibodyantibody detects endogenous levels of RXFP2.

Aufreinigung: Immunoaffinity purified

Immunogen: Synthetic peptide from human RXFP2 (aa103-152).

Type of Immunogen: Synthetic peptide

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: Peptide-ELISA (1:10000), WB (1:500 - 1:1000)

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS,  pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C.

Details zu RXFP2

Target: RXFP2 (Relaxin/insulin-Like Family Peptide Receptor 2 (RXFP2))

Andere Bezeichnung: RXFP2 / LGR8 (RXFP2 Produkte)

Synonyme: GPR106 antikoerper, GREAT antikoerper, INSL3R antikoerper, LGR8 antikoerper, LGR8.1 antikoerper, RXFPR2 antikoerper, Gpcr antikoerper, Lgr8 antikoerper, Gpr106 antikoerper, Great antikoerper, lgr8.1 antikoerper, rxfp2 antikoerper, rxfp2b antikoerper, zgc:63668 antikoerper, relaxin/insulin like family peptide receptor 2 antikoerper, relaxin/insulin-like family peptide receptor 2 antikoerper, relaxin/insulin-like family peptide receptor 2a antikoerper, RXFP2 antikoerper, Rxfp2 antikoerper, rxfp2a antikoerper

Hintergrund: Name/Gene ID: RXFP2
Subfamily: Relaxin
Family: GPCR

Synonyms: RXFP2, G-protein coupled receptor 106, GPR106, INSL3R, LGR8, GREAT, Relaxin receptor 2, LGR8.1, RXFPR2

Gen-ID: 122042

UniProt: Q8WXD0

Pathways: cAMP Metabolic Process, Myometrial Relaxation and Contraction